Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Shin Nippon Biomedical Laboratories Ltd. | 0 | 1 | 0 | 0 | €7.50 | - | - |
| Sage Therapeutics Inc. | 5 | 2 | 0 | 0 | €7.11 | €21.44 | 201.354% |
| BioLine RX Ltd ADR | 0 | 1 | 0 | 0 | €0.62 | - | - |
| Bluebird Bio Inc. | 7 | 6 | 3 | 0 | €0.56 | €5.47 | 874.093% |
| Biofrontera AG | 0 | 1 | 0 | 0 | €0.33 | - | - |
| Fate Therapeutics Inc. | 4 | 3 | 1 | 0 | €3.22 | €7.31 | 127.384% |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.12 | - | - |
| Medigene AG | 1 | 1 | 0 | 0 | €1.06 | - | - |
| Amarin Corp. ADR | 2 | 1 | 0 | 0 | €0.54 | - | - |
| Protalix Biotherapeutics Inc. | 1 | 1 | 0 | 0 | €0.82 | €2.00 | 144.320% |
| Natural Alternat. | 19 | 1 | 0 | 0 | €4.72 | - | - |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €36.20 | €50.00 | 38.122% |
| Uniqure B.V. | 1 | 2 | 0 | 0 | €5.46 | €11.00 | 101.539% |
| Rocket Pharmaceuticals Inc | 2 | 1 | 0 | 0 | ? | €32.00 | 92.019% |
| Enlivex Therapeutics Ltd. | 0 | 1 | 0 | 0 | €1.07 | - | - |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.03 | €50.00 | 4744.961% |
| Viking Therapeutics Inc | 5 | 1 | 0 | 1 | €55.44 | - | - |
| Bristol-Myers Squibb | 7 | 3 | 0 | 1 | €44.26 | €67.64 | 52.822% |
| Evoke Pharma Inc. | 0 | 24 | 0 | 1 | €0.37 | - | - |
| Cara Therapeutics Inc. | 10 | 6 | 0 | 2 | €0.32 | €4.61 | 1357.612% |
| AEterna Zentaris Inc. | 2 | 22 | 0 | 2 | €1.87 | €8.51 | 355.096% |
| Moleculin Biotech Inc | 3 | 25 | 0 | 2 | €0.41 | €18.42 | 4393.659% |
| Trevena Inc. | 2 | 23 | 0 | 3 | €0.15 | €6.48 | 4136.601% |
| Glycomimetics Inc. | 3 | 6 | 0 | 3 | €0.15 | €9.13 | 5909.605% |